• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    12 Health Care Stocks Moving In Tuesday's Pre-Market Session

    6/4/24 8:06:42 AM ET
    $ANL
    $ANNX
    $BPTH
    $FRES
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $ANL alert in real time by email

    Gainers

    • Annexon (NASDAQ:ANNX) shares increased by 57.2% to $7.2 during Tuesday's pre-market session. The market value of their outstanding shares is at $665.3 million.
    • Fresh2 Group (NASDAQ:FRES) shares moved upwards by 36.08% to $0.48. The company's market cap stands at $11.8 million.
    • SunLink Health Systems (AMEX:SSY) stock moved upwards by 32.45% to $0.8. The market value of their outstanding shares is at $5.6 million.
    • Adlai Nortye (NASDAQ:ANL) stock moved upwards by 15.96% to $7.12. The market value of their outstanding shares is at $262.7 million.
    • TRACON Pharma (NASDAQ:TCON) shares rose 15.74% to $1.47. The market value of their outstanding shares is at $3.9 million.
    • Kindly MD (NASDAQ:KDLY) stock increased by 15.41% to $3.07. The company's market cap stands at $18.3 million.

    Losers

    • Bio-Path Hldgs (NASDAQ:BPTH) shares declined by 24.1% to $2.45 during Tuesday's pre-market session. The market value of their outstanding shares is at $4.0 million.
    • Exicure (NASDAQ:XCUR) shares declined by 9.3% to $0.49. The market value of their outstanding shares is at $4.2 million.
    • Sharps Technology (NASDAQ:STSS) shares decreased by 8.88% to $0.35. The market value of their outstanding shares is at $5.4 million.
    • MyMD Pharmaceuticals (NASDAQ:MYMD) shares decreased by 8.17% to $1.8. The company's market cap stands at $4.1 million.
    • NewGenIvf Group (NASDAQ:NIVF) stock decreased by 7.98% to $1.27. The market value of their outstanding shares is at $12.8 million.
    • Mainz Biomed (NASDAQ:MYNZ) shares decreased by 7.84% to $0.8. The company's market cap stands at $17.5 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

    This article was generated by Benzinga's automated content engine and reviewed by an editor.

    Get the next $ANL alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ANL
    $ANNX
    $BPTH
    $FRES

    CompanyDatePrice TargetRatingAnalyst
    Adlai Nortye Ltd.
    $ANL
    2/13/2026$16.00Neutral → Buy
    H.C. Wainwright
    Annexon Inc.
    $ANNX
    12/23/2025$16.00Buy
    Chardan Capital Markets
    Adlai Nortye Ltd.
    $ANL
    6/2/2025Buy → Neutral
    H.C. Wainwright
    Mainz Biomed N.V.
    $MYNZ
    2/14/2025$14.00Buy
    Maxim Group
    Mainz Biomed N.V.
    $MYNZ
    11/25/2024Buy → Neutral
    H.C. Wainwright
    Adlai Nortye Ltd.
    $ANL
    9/4/2024$9.00Buy
    H.C. Wainwright
    Annexon Inc.
    $ANNX
    3/1/2024$11.00Neutral → Overweight
    JP Morgan
    Annexon Inc.
    $ANNX
    12/21/2023$4.00 → $6.00Neutral → Buy
    BofA Securities
    More analyst ratings

    $ANL
    $ANNX
    $BPTH
    $FRES
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    NewGen Signs MOU with Women in Web3 Hong Kong to Launch Regional Women's Health Awareness Initiative

    BANGKOK, March 02, 2026 (GLOBE NEWSWIRE) -- NewGenIVF Group (NASDAQ:NIVF) ("NewGen" or the "Company"), a technology-driven, diversified growth company, today announced that it has entered into a Memorandum of Understanding ("MOU") with Women in Web3 Hong Kong Limited ("WiW3"), a leading community organization dedicated to advancing women and their allies in Hong Kong's Web3 ecosystem. Under the MOU, NewGen and WiW3 intend to collaborate on a co-branded public awareness and education campaign anchored by the NewGen manifesto and petition, with a primary focus on women's health literacy. The campaign will spotlight themes such as the urgency of improved education on women's health, the impa

    3/2/26 8:30:00 AM ET
    $NIVF
    Misc Health and Biotechnology Services
    Health Care

    Sharps Technology and The Tie Announce Strategic Collaboration to Advance Institutional Participation in the Solana Ecosystem

    NEW YORK, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. ("STSS" or the "Company") (NASDAQ:STSS), a medical device company with a Solana digital asset treasury strategy, and The Tie, Inc. ("The Tie"), the leading provider of institutional-grade digital asset analytics, compliant communications, and infrastructure services, today announced a strategic collaboration to strengthen Solana's institutional infrastructure and expand institutional access to the ecosystem. Under the collaboration, STSS will delegate a portion of its SOL treasury holdings, currently more than 2 million SOL, to Stakin by The Tie, which operates non-custodial validator infrastructure across 40+ proof-o

    2/25/26 9:00:00 AM ET
    $STSS
    Medical/Dental Instruments
    Health Care

    NewGen Provides Recap of Strategic Progress as Diversification Fuels Success, Positions Company for Breakout Year

    BANGKOK, Feb. 24, 2026 (GLOBE NEWSWIRE) -- NewGenIVF Group (NASDAQ:NIVF) ("NewGen" or the "Company"), a technology-driven, diversified growth company, today outlined its remarkable financial and operational transformation, positioning the Company for significant value creation in 2026 and beyond. Over the past year, NewGen has successfully executed an extensive strategic pivot, building a robust balance sheet and a dynamic portfolio of high-growth international ventures. NewGen has completed a decisive corporate transformation, strengthening its foundation for accelerated growth. Through a proactive capital management strategy and strategic asset deployment, the Company has dramatically i

    2/24/26 8:30:00 AM ET
    $NIVF
    Misc Health and Biotechnology Services
    Health Care

    $ANL
    $ANNX
    $BPTH
    $FRES
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Adlai Nortye Ltd. upgraded by H.C. Wainwright with a new price target

    H.C. Wainwright upgraded Adlai Nortye Ltd. from Neutral to Buy and set a new price target of $16.00

    2/13/26 9:51:23 AM ET
    $ANL
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Chardan Capital Markets initiated coverage on Annexon with a new price target

    Chardan Capital Markets initiated coverage of Annexon with a rating of Buy and set a new price target of $16.00

    12/23/25 8:41:58 AM ET
    $ANNX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Adlai Nortye Ltd. downgraded by H.C. Wainwright

    H.C. Wainwright downgraded Adlai Nortye Ltd. from Buy to Neutral

    6/2/25 11:24:27 AM ET
    $ANL
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ANL
    $ANNX
    $BPTH
    $FRES
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    EVP & CHIEF SCIENTIFIC OFFICER Artis Dean Richard sold $32,004 worth of shares (5,894 units at $5.43), decreasing direct ownership by 3% to 180,093 units (SEC Form 4)

    4 - Annexon, Inc. (0001528115) (Issuer)

    3/4/26 4:30:41 PM ET
    $ANNX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    EVP & CHIEF FINANCIAL OFFICER Lew Jennifer sold $30,162 worth of shares (5,565 units at $5.42), decreasing direct ownership by 3% to 170,700 units (SEC Form 4)

    4 - Annexon, Inc. (0001528115) (Issuer)

    3/4/26 4:30:38 PM ET
    $ANNX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    EVP & CHIEF BUSINESS OFFICER Overdorf Michael sold $23,517 worth of shares (4,339 units at $5.42), decreasing direct ownership by 2% to 182,625 units (SEC Form 4)

    4 - Annexon, Inc. (0001528115) (Issuer)

    3/4/26 4:30:45 PM ET
    $ANNX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ANL
    $ANNX
    $BPTH
    $FRES
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Amendment: Large owner Donahue Kevin Michael bought $1,034,350 worth of shares (685,000 units at $1.51) (SEC Form 4)

    4/A - MAINZ BIOMED N.V. (0001874252) (Issuer)

    1/20/26 10:29:36 AM ET
    $MYNZ
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Large owner Donahue Kevin Michael bought $258,827,700,000 worth of shares (643,850 units at $402,000.00) (SEC Form 4)

    4 - MAINZ BIOMED N.V. (0001874252) (Issuer)

    1/16/26 3:42:37 PM ET
    $MYNZ
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Carson William H. bought $20,657 worth of shares (4,115 units at $5.02), increasing direct ownership by 8% to 54,405 units (SEC Form 4)

    4 - Annexon, Inc. (0001528115) (Issuer)

    1/2/26 4:30:06 PM ET
    $ANNX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ANL
    $ANNX
    $BPTH
    $FRES
    SEC Filings

    View All

    SEC Form F-1 filed by NewGenIvf Group Limited

    F-1 - NewGenIvf Group Ltd (0001981662) (Filer)

    3/2/26 5:30:55 PM ET
    $NIVF
    Misc Health and Biotechnology Services
    Health Care

    SEC Form 144 filed by Annexon Inc.

    144 - Annexon, Inc. (0001528115) (Subject)

    3/2/26 4:02:33 PM ET
    $ANNX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 1-Z filed by Bio-Path Holdings Inc.

    1-Z - BIO-PATH HOLDINGS, INC. (0001133818) (Filer)

    2/25/26 4:44:21 PM ET
    $BPTH
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ANL
    $ANNX
    $BPTH
    $FRES
    Financials

    Live finance-specific insights

    View All

    Annexon Reports Third Quarter 2025 Financial Results, Portfolio Progress and Key Anticipated Milestones

    Late-Stage Neuroinflammation Platform Advancing Global Registrational Programs in Guillain-Barré Syndrome (GBS) and Geographic Atrophy (GA) Current Tanruprubart GBS Dossier On Track for MAA Filing in January 2026; Potential to Be the First Approved Targeted and Fast-Acting Therapy for the Treatment of GBS; Continued FDA Discussions Regarding Generalizability Package in Support of BLA Filing Topline ARCHER II Pivotal Data for Vonaprument in Dry AMD with GA on Track for Second Half of 2026; Potential to Be the First Approved Vision Sparing Therapy for the Treatment of Eight Million GA Patients Worldwide ANX1502 Cold Agglutinin Disease (CAD) Proof of Concept Study Ongoing with Expected 2026

    11/10/25 4:05:00 PM ET
    $ANNX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Exicure, Inc. Reports Third Quarter 2025 Financial Results

    REDWOOD CITY, Calif., Nov. 07, 2025 (GLOBE NEWSWIRE) -- Exicure, Inc. (NASDAQ:XCUR, the "Company")) releases the following financial results for the fiscal quarter ended September 30, 2025. Third Quarter 2025 Financial Results Cash Position: Cash and cash equivalents were $4.4 million as of September 30, 2025, as compared to $12.5 million as of December 31, 2024. Research and Development (R&D) Expense: Research and development expenses were $0.9 million for the quarter ended September 30, 2025, as compared to $0 for the quarter ended September 30, 2024. The increase in R&D expense of $0.9 million for the three months ended September 30, 2025 was due to incurring research and developmen

    11/7/25 4:00:00 PM ET
    $XCUR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Sharps Technology, Inc. Acquires Over 2 Million SOL, the Native Asset of Solana, the Fastest and Most Used Public Blockchain

    NEW YORK, Sept. 2, 2025 /PRNewswire/ -- Sharps Technology, Inc. (the "Company" or "Sharps Technology") (Nasdaq: "STSS" and "STSSW") today announced its first acquisition of Solana ("SOL") tokens as part of its digital asset treasury strategy under which the principal holding will be SOL, the native digital asset of the Solana blockchain. Funded from the Company's recent PIPE equity raise, Sharps Technology now holds over 2 million SOL, creating a SOL treasury currently valued north of $400M. Sharps Technology intends to provide regular updates on its SOL holdings and performan

    9/2/25 7:00:00 AM ET
    $STSS
    Medical/Dental Instruments
    Health Care

    $ANL
    $ANNX
    $BPTH
    $FRES
    Leadership Updates

    Live Leadership Updates

    View All

    NIVF Appoints Award-Winning Web3 Leader Joshua Chu to Spearhead Tokenization Strategy and Formally Engages Evident Capital to Launch Up to USD 30 Million in Tokenized Bonds by Q1, Outlining 2026 Value Catalysts

    BANGKOK, Jan. 21, 2026 (GLOBE NEWSWIRE) -- NewGenIVF Group Limited (("NewGen" or the "Company, NASDAQ:NIVF), a technology-driven company building a diversified ecosystem across fertility technology, digital assets, and real estate development, today announced the appointment of award-winning Web3 legal and regulatory specialist Joshua Chu as Senior Counsel to lead the Group's tokenization strategy, alongside the formal engagement of Evident Capital, Hong Kong's first fully integrated, SFC-licensed tokenization and alternative assets platform, to support the launch of NIVF's inaugural tokenized bond issuance of up to USD 30 million targeted for completion by the first quarter of 2026. As S

    1/21/26 8:30:00 AM ET
    $NIVF
    Misc Health and Biotechnology Services
    Health Care

    NewGenDigital Appointed as SAXA Inc.'s Agent for Tokenization of US$100 Million of Gold-backed Assets

    Service agreement with SAXA, Inc. appoints NewGenDigital as SAXA's worldwide tokenization agent, strengthening cooperation between the two companies ahead of proposed reverse merger Value of tokenized assets could be expanded to US$1 billion under the terms of the agreement; NewGenDigital to earn 5% commission on assets sold BANGKOK, Nov. 05, 2025 (GLOBE NEWSWIRE) -- NewGenIvf Group Limited (NASDAQ:NIVF) ("NewGen" or the "Company"), a tech-forward, diversified, multi-jurisdictional high-growth entity transforming industries through innovative solutions across real estate development, digital asset management and reproductive health solutions, today announced that its subsidiary, NewGenD

    11/5/25 9:00:00 AM ET
    $NIVF
    Misc Health and Biotechnology Services
    Health Care

    Mainz Biomed to Present the Future of Colorectal Cancer Screening at WEO CRC Screening Committee Meeting

    BERKELEY, Calif. and MAINZ, Germany, Sept. 30, 2025 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ) ("Mainz Biomed" or the "Company"), a molecular genetics diagnostic company specializing in the early detection of cancer, is pleased to announce its participation in the upcoming Colorectal Cancer (CRC) Screening Committee Plenary Meeting and Expert Working Group (EWG) Sessions hosted by the World Endoscopy Organization (WEO), taking place on October 3rd, 2025, in Berlin, Germany. This high-level gathering brings together global leaders in colorectal cancer screening to evaluate emerging technologies, exchange scientific insights, and help shape future strategies for early detection

    9/30/25 8:01:00 AM ET
    $MYNZ
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ANL
    $ANNX
    $BPTH
    $FRES
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by NewGenIvf Group Limited

    SC 13G - NewGenIvf Group Ltd (0001981662) (Subject)

    12/5/24 8:23:57 PM ET
    $NIVF
    Misc Health and Biotechnology Services
    Health Care

    SEC Form SC 13D filed by Exicure Inc.

    SC 13D - EXICURE, INC. (0001698530) (Subject)

    11/29/24 5:51:28 PM ET
    $XCUR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by TRACON Pharmaceuticals Inc.

    SC 13G/A - Tracon Pharmaceuticals, Inc. (0001394319) (Subject)

    11/14/24 8:51:58 PM ET
    $TCON
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care